Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bendroflumethiazide 2.5mg tablets
0202010B0AAABAB
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | 1,118,314 |
|
Bendroflumethiazide 5mg tablets
0202010B0AAACAC
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | 45,989 |
|
Bendroflumethiazide 2.5mg/5ml oral suspension
0202010B0AAAXAX
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | 168 |
|
Bendroflumethiazide 1.25mg/5ml oral suspension
0202010B0AAAUAU
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | 6 |
|
Bendroflumethiazide 5mg/5ml oral suspension
0202010B0AAAQAQ
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | 1 |
|
Bendroflumethiazide 1mg/5ml oral suspension
0202010B0AAAWAW
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | No data available |
|
Bendroflumethiazide 2mg/5ml oral liquid
0202010B0AAASAS
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | No data available |
|
Bendroflumethiazide 3.75mg/5ml oral liquid
0202010B0AAAVAV
|
Bendroflumethiazide | Bendroflumethiazide | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.